Hepatitis B Reactivation in a Patient Receiving Chemotherapy for Breast Cancer: A Case Report

被引：4
|
作者：
Remo, Mylene [1 ]
Abraham, Ivy [1 ]
Kankanala, Vineel [2 ]
Chacra, Wadih [2 ]
Danciu, Oana C. [1 ]
机构：
[1] Univ Illinois, Coll Med, Div Hematol Oncol, 840 South Wood St,Room 832,MC 713, Chicago, IL 60612 USA
[2] Univ Illinois, Coll Med, Div Gastroenterol & Hepatol, Chicago, IL USA
来源：
ANTICANCER RESEARCH | 2017年 / 37卷 / 07期
关键词：
Breast cancer; chemotherapy; hepatitis B; liver failure; screening; VIRUS REACTIVATION; MANAGEMENT; PREVENTION;
D O I：
10.21873/anticanres.11755
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Hepatitis B virus (HBV) reactivation is a known complication of immunosuppressive therapy. While patients who are undergoing treatment with anti-CD20 agents or stem cell transplantation are commonly screened for chronic HBV infection prior to treatment, there are no consensus guidelines regarding HBV screening for patients undergoing chemotherapy for solid tumors. We present a rare case of fulminant liver failure due to HBV reactivation in a patient receiving chemotherapy for breast cancer. Our case highlights the importance of developing definitive guidelines regarding HBV screening in patients receiving chemotherapy for solid tumors and raises the question of the need for universal screening.
引用
收藏
页码：3791 / 3793
页数：3
相关论文
共 50 条
12345